<DOC>
	<DOC>NCT03062748</DOC>
	<brief_summary>The purpose of the study is to compare the relative contribution of systemic inflammation vs. Obstructive Sleep Apnea (OSA) severity (as measured by Apnea Hypopnea Index) in predicting cardiovascular and metabolic aberrations associated with mild-to-moderate obstructive sleep apnea.</brief_summary>
	<brief_title>Predicting Cardiometabolic Risk in Mild-to-Moderate Obstructive Sleep Apnea: Inflammation vs. Apnea/Hypopnea Index</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea, Obstructive</mesh_term>
	<criteria>Mild to moderate OSA (5≤ AHI &lt;30) BMI ≤ 45 Age ≥ 18 Men &amp; Women AHI ≥ 30 BMI &gt;45 Current use of steroids or antiinflammatory medication Diagnosis of insulin dependent diabetes Diagnosis of autoimmune disorder Shiftwork Current use of CPAP</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>